Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Lewis Acid Catalyzed Bromination. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN102260154A details high-yield catalytic bromination for Rimonabant intermediates. Offers cost reduction and supply chain reliability for global pharmaceutical manufacturing partners.
Patent CN108069860B details a high-yield Lewis acid-catalyzed bromination route for o-nitrobenzyl bromide, offering significant cost reduction in pharmaceutical intermediates manufacturing and enhanced supply chain stability.
Patent CN112679420B reveals a safe, two-step synthesis of 2,5-dibromopyridine avoiding diazonium salts. Achieves >99.5% purity with reduced wastewater for pharma intermediates.